- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (880)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1762)
My bladder cancer journey
3 minute read | Published September 09, 2014
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on September 09, 2014
In June 2009, I noticed a tinge of blood in my urine, but I quickly dismissed it because I had bigger fish to fry at the time. My husband's business had suffered financial losses, and we had just sent our daughter to a long-term treatment program across the country. I never thought it could be a bladder cancer symptom.
In August, I finally made an appointment with a local urologist, thinking I had a mild urinary tract infection (UTI). I went alone with the intentions of returning to work after the appointment. The urine specimen they collected showed traces of blood, but no bacteria.
A cystoscopy was performed and revealed a tumor at the dome of the bladder. I calmly asked, "Could it be cancer?" The doctor responded, "It likely is."
My bladder cancer diagnosis and treatment
A few weeks later, I underwent a transurethral resection (TUR), a surgery in which the tumor is scraped from the bladder, then a partial cystectomy. Both confirmed that I had urachal adenocarcinoma, a rare type of bladder cancer. It represents less than 0.5 to 2% of all bladder cancers, and research showed survival at less than a year.
All I could think about was that I could not die because my family needed me. Yes, you could say I was a control freak and thought the world would not go on without me.
I was referred to a local oncologist who said he had never seen this cancer in his 26 years of practice. In our conversation, I mentioned a previous X-ray that showed a spot on my right lung diagnosed as a granuloma, an inflammation of the tissue. The oncologist ordered a PET scan and then a biopsy of my lung.
Because there was no protocol for treatment, he referred me to MD Anderson.
The biopsy report came back the day I arrived at MD Anderson for an appointment with Padmanee Sharma, M.D., in Genitourinary Medical Oncology. She told me I have stage 4 bladder cancer with distant metastasis to the lung. She drew a bell curve with 6 months at the top showing the average survival rate. I was offered the opportunity to participate in a clinical trial under Dr. Seifker-Radtke, and my thought was, "What do I have to lose?"
Why I haven't given up
I took many chemotherapy drugs off and on, both as an inpatient and outpatient. I experienced all the common side effects, including hair loss. I had radiation and later a wedge resection to my right lung.
In May 2012, it was a pleasure to hear the words "in complete remission," even if it lasted only a little more than a year. In September 2013, a CT scan revealed the airway leaving my right lung was blocked, a portion of the remaining lung collapsed, and new tumor growth outside the lung in the chest.
A bronchoscope confirmed we were again dealing with metastatic disease. We tried chemotherapy until my immune system was too compromised, then transitioned to a maintenance drug.
In August 2014, CT scans showed the tumors growing, and I was taken off of all treatment. The next step is to see if I qualify for a new phase I clinical trial that targets a specific mutation identified in my tumor tissue. Neither my oncologist nor I are ready to quit.
Through this journey I have learned much about life and myself. Each day I put on my bright lipstick and earrings and charge forward, not allowing cancer to take life from me. I work, I play, I relax, I meditate. I seek balance in my life.
Oddly enough, cancer has been a blessing. It brought me to my knees to find peace within through surrender. I learned that the material things in my life mean little, and that my faith and my relationships mean everything.